230 related articles for article (PubMed ID: 33212876)
1. Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors.
Çeçen M; Oh JM; Özdemir Z; Büyüktuncel SE; Uysal M; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Mathew B; Kim H
Molecules; 2020 Nov; 25(22):. PubMed ID: 33212876
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors.
Özdemir Z; Alagöz MA; Uslu H; Karakurt A; Erikci A; Ucar G; Uysal M
Pharmacol Rep; 2020 Jun; 72(3):692-704. PubMed ID: 32144745
[TBL] [Abstract][Full Text] [Related]
3. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library.
Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S
Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors.
Kumar B; Sheetal ; Mantha AK; Kumar V
Bioorg Chem; 2018 Apr; 77():252-262. PubMed ID: 29421700
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, in vitro, and in silico studies of 1,2,4-triazole-piperazine hybrid derivatives as potential MAO inhibitors.
Uslu H; Osmaniye D; Sağlik BN; Levent S; Özkay Y; Benkli K; Kaplancikli ZA
Bioorg Chem; 2021 Dec; 117():105430. PubMed ID: 34678603
[TBL] [Abstract][Full Text] [Related]
6. Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach.
Nair AS; Oh JM; Koyiparambath VP; Kumar S; Sudevan ST; Soremekun O; Soliman ME; Khames A; Abdelgawad MA; Pappachen LK; Mathew B; Kim H
Molecules; 2021 May; 26(11):. PubMed ID: 34071665
[TBL] [Abstract][Full Text] [Related]
7. Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors.
Alagöz MA; Oh JM; Zenni YN; Özdemir Z; Abdelgawad MA; Naguib IA; Ghoneim MM; Gambacorta N; Nicolotti O; Kim H; Mathew B
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744926
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors.
Sağlık BN; Cebeci O; Acar Çevik U; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Sep; 25(18):. PubMed ID: 32971892
[TBL] [Abstract][Full Text] [Related]
9. Pyridazinones containing dithiocarbamoyl moieties as a new class of selective MAO-B inhibitors.
Besada P; Viña D; Costas T; Costas-Lago MC; Vila N; Torres-Terán I; Sturlese M; Moro S; Terán C
Bioorg Chem; 2021 Oct; 115():105203. PubMed ID: 34371375
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors.
Costas-Lago MC; Besada P; Rodríguez-Enríquez F; Viña D; Vilar S; Uriarte E; Borges F; Terán C
Eur J Med Chem; 2017 Oct; 139():1-11. PubMed ID: 28797881
[TBL] [Abstract][Full Text] [Related]
12. Design of enamides as new selective monoamine oxidase-B inhibitors.
Kavully FS; Oh JM; Dev S; Kaipakasseri S; Palakkathondi A; Vengamthodi A; Abdul Azeez RF; Tondo AR; Nicolotti O; Kim H; Bijo Mathew
J Pharm Pharmacol; 2020 Jul; 72(7):916-926. PubMed ID: 32246471
[TBL] [Abstract][Full Text] [Related]
13. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors.
Parambi DGT; Oh JM; Baek SC; Lee JP; Tondo AR; Nicolotti O; Kim H; Mathew B
Bioorg Chem; 2019 Dec; 93():103335. PubMed ID: 31606547
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and inhibition study of monoamine oxidase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by 3,8-substituted 5H-indeno[1,2-c]pyridazin-5-one derivatives.
Reniers J; Meinguet C; Moineaux L; Masereel B; Vincent SP; Frederick R; Wouters J
Eur J Med Chem; 2011 Dec; 46(12):6104-11. PubMed ID: 22018876
[TBL] [Abstract][Full Text] [Related]
16. Rational approaches towards reversible inhibition of type B monoamine oxidase. Design and evaluation of a novel 5H-Indeno[1,2-c]pyridazin-5-one derivative.
Ooms F; Frédérick R; Durant F; Petzer JP; Castagnoli N; Van der Schyf CJ; Wouters J
Bioorg Med Chem Lett; 2003 Jan; 13(1):69-73. PubMed ID: 12467619
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of 1, 4-benzodioxan-substituted chalcones as selective and reversible inhibitors of human monoamine oxidase B.
Kong Z; Sun D; Jiang Y; Hu Y
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1513-1523. PubMed ID: 32705910
[TBL] [Abstract][Full Text] [Related]
18. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
Zarmouh NO; Eyunni SK; Soliman KF
BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of 2-(indolylmethylidene)-2,3-dihydro-1-benzofuran-3-one and 2-(indolyl)-4H-chromen-4-one derivatives as novel monoamine oxidases inhibitors.
Takao K; U S; Kamauchi H; Sugita Y
Bioorg Chem; 2019 Jun; 87():594-600. PubMed ID: 30933784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
